SPECIFICAL INTERACTIONS BETWEEN NEWLY IDENTIFIED HUMAN KINASES, MEK5 AND ERK5

被引：0
|
作者：
ZHOU, GC [1 ]
BAO, A [1 ]
GUAN, KL [1 ]
DIXON, JE [1 ]
机构：
[1] UNIV MICHIGAN, SCH MED, DEPT BIOL CHEM, ANN ARBOR, MI 48109 USA
来源：
FASEB JOURNAL | 1995年 / 9卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1306 / A1306
页数：1
相关论文
共 50 条
  • [31] MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis
    Antoon, James W.
    Martin, Elizabeth C.
    Lai, Rongye
    Salvo, Virgilo A.
    Tang, Yan
    Nitzchke, Ashley M.
    Elliott, Steven
    Nam, Seung Yoon
    Xiong, Wei
    Rhodes, Lyndsay V.
    Collins-Burow, Bridgette
    David, Odile
    Wang, Guandi
    Shan, Bin
    Beckman, Barbara S.
    Nephew, Kenneth P.
    Burow, Matthew E.
    PLOS ONE, 2013, 8 (08):
  • [32] A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer
    Regan Odongo
    Asuman Demiroglu-Zergeroglu
    Tunahan Çakır
    BioData Mining, 17
  • [33] A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer
    Odongo, Regan
    Demiroglu-Zergeroglu, Asuman
    Cakir, Tunahan
    BIODATA MINING, 2024, 17 (01)
  • [34] SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling
    Mansour, Mohammed A.
    Hyodo, Toshinori
    Ito, Satoko
    Kurita, Kenji
    Kokuryo, Toshio
    Uehara, Keisuke
    Nagino, Masato
    Takahashi, Masahide
    Hamaguchi, Michinari
    Senga, Takeshi
    FEBS JOURNAL, 2015, 282 (08) : 1394 - 1405
  • [35] Association of ERK5 with MEK5 (upstream kinase of ERK5), but not ERK5 kinase activation, inhibits small ubiquitin-related modification of ERK5 kinase (ERK5-SUMOylation), and prevents diabetes (DM)-mediated exacerbation of left ventricular (LV) remodeling after myocardial infarction (MI)
    Shishido, Tetsuro
    Woo, Chang-Hoon
    Ding, Bo
    McMclain, Carolyn
    Lu, Zhilbo
    Xu, Haodong
    Yan, Chen
    Abe, Jun-ichi
    CIRCULATION, 2007, 116 (16) : 211 - 211
  • [36] Analysis of aryl substitution and intramolecular ligand H-bonding in selective inhibitors of the MEK5/ERK5 cascade
    Flaherty, Patrick T.
    Cavanaugh, Jane C.
    Gupta, Mohit
    Vechery, Colin
    Chakrabarty, Suravi
    Monlish, Darlene
    Wright, Thomas
    CANCER RESEARCH, 2015, 75
  • [37] N-arylated 2-amino fused thiophene analogs as potential MEK5/ERK5 pathway inhibitors
    Gupta, Mohit
    Flaherty, Patrick
    Wright, Thomas
    Cavanaugh, Jane
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [38] Dual inhibition of the PI3k/Akt and MEK5/ERK5 pathways in tamoxifen resistant breast cancer
    Wright, Thomas D.
    Hasan, Mahmud
    Witt-Enderby, Paula
    Cavanaugh, Jane
    CANCER RESEARCH, 2017, 77
  • [39] Evaluation of synergistic PI3K/Akt and MEK5/ERK5 inhibition in triple-negative breast cancer
    Wright, Thomas D.
    Raybuck, Christopher
    Gartland, Nathan
    Wendekier, Katy
    Monlish, Darlene
    Chakrabarty, Suravi
    Flaherty, Patrick T.
    Burow, Matthew E.
    Cavanaugh, Jane E.
    CANCER RESEARCH, 2018, 78 (13)
  • [40] LOCALIZATION OF THE MITOGEN-ACTIVATED PROTEIN-KINASE ERK5 AND ITS UPSTREAM ACTIVATOR MEK5 IN RAT-BRAIN
    CHAO, HHJ
    KWAK, SP
    DIXON, JE
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 736 - 736
12345